Vitrolife AB (publ) (VTRLY)
OTCMKTS · Delayed Price · Currency is USD
16.39
0.00 (0.00%)
May 27, 2025, 4:00 PM EDT

Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of 2.16 billion. The enterprise value is 2.25 billion.

Market Cap 2.16B
Enterprise Value 2.25B

Important Dates

The next estimated earnings date is Thursday, July 17, 2025.

Earnings Date Jul 17, 2025
Ex-Dividend Date May 2, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +0.10%
Shares Change (QoQ) -0.21%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 75.04M

Valuation Ratios

The trailing PE ratio is 43.50 and the forward PE ratio is 34.61.

PE Ratio 43.50
Forward PE 34.61
PS Ratio 6.00
PB Ratio 1.65
P/TBV Ratio n/a
P/FCF Ratio 31.62
P/OCF Ratio 27.84
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.08, with an EV/FCF ratio of 32.99.

EV / Earnings 45.38
EV / Sales 6.01
EV / EBITDA 18.08
EV / EBIT 28.05
EV / FCF 32.99

Financial Position

The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.15.

Current Ratio 3.77
Quick Ratio 2.98
Debt / Equity 0.15
Debt / EBITDA 1.62
Debt / FCF 2.85
Interest Coverage 8.41

Financial Efficiency

Return on equity (ROE) is 3.78% and return on invested capital (ROIC) is 3.18%.

Return on Equity (ROE) 3.78%
Return on Assets (ROA) 2.89%
Return on Invested Capital (ROIC) 3.18%
Return on Capital Employed (ROCE) 4.83%
Revenue Per Employee 312,731
Profits Per Employee 43,141
Employee Count 1,169
Asset Turnover 0.22
Inventory Turnover 3.64

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +23.23% in the last 52 weeks. The beta is 1.83, so Vitrolife AB's price volatility has been higher than the market average.

Beta (5Y) 1.83
52-Week Price Change +23.23%
50-Day Moving Average 17.51
200-Day Moving Average 19.69
Relative Strength Index (RSI) 0.08
Average Volume (20 Days) 27

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of 359.64 million and earned 49.61 million in profits. Earnings per share was 0.37.

Revenue 359.64M
Gross Profit 213.39M
Operating Income 77.11M
Pretax Income 66.85M
Net Income 49.61M
EBITDA 114.77M
EBIT 77.11M
Earnings Per Share (EPS) 0.37
Full Income Statement

Balance Sheet

The company has 105.00 million in cash and 194.37 million in debt, giving a net cash position of -89.36 million.

Cash & Cash Equivalents 105.00M
Total Debt 194.37M
Net Cash -89.36M
Net Cash Per Share n/a
Equity (Book Value) 1.31B
Book Value Per Share 9.66
Working Capital 166.77M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 77.51 million and capital expenditures -9.26 million, giving a free cash flow of 68.24 million.

Operating Cash Flow 77.51M
Capital Expenditures -9.26M
Free Cash Flow 68.24M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 59.34%, with operating and profit margins of 21.44% and 13.80%.

Gross Margin 59.34%
Operating Margin 21.44%
Pretax Margin 18.59%
Profit Margin 13.80%
EBITDA Margin 31.91%
EBIT Margin 21.44%
FCF Margin 18.98%

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 0.42%.

Dividend Per Share 0.07
Dividend Yield 0.42%
Dividend Growth (YoY) 25.81%
Years of Dividend Growth 2
Payout Ratio 27.11%
Buyback Yield -0.10%
Shareholder Yield 0.32%
Earnings Yield 2.30%
FCF Yield 3.16%
Dividend Details

Stock Splits

The last stock split was on June 1, 2018. It was a forward split with a ratio of 1.25.

Last Split Date Jun 1, 2018
Split Type Forward
Split Ratio 1.25

Scores

Vitrolife AB has an Altman Z-Score of 5.17.

Altman Z-Score 5.17
Piotroski F-Score n/a